US equities
|
NVDA
$239.58
▲+2.41%
SPCX
$169.83
▲+6.84%
MU
$1,061.92
▼-1.21%
TSLA
$379.82
▲+2.49%
SNDK
$1,701.49
▼-1.08%
MSFT
$527.75
▲+1.97%
INTC
$116.16
▼-2.66%
META
$743.00
▲+2.05%
NVDA
$239.58
▲+2.41%
SPCX
$169.83
▲+6.84%
MU
$1,061.92
▼-1.21%
TSLA
$379.82
▲+2.49%
SNDK
$1,701.49
▼-1.08%
MSFT
$527.75
▲+1.97%
INTC
$116.16
▼-2.66%
META
$743.00
▲+2.05%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Articles published by Tenaya Therapeutics
Tenaya Therapeutics to Participate in Upcoming Investor and Industry Conferences
September 30, 2021
From
Tenaya Therapeutics
Via
Business Wire
Tickers
TNYA
Tenaya Therapeutics Unveils Preclinical Research Supporting Product Candidate for Rare and Prevalent Heart Disease Indications at ESC Heart Failure 2021
July 13, 2021
From
Tenaya Therapeutics
Via
Business Wire
Tenaya Therapeutics Announces New Appointments to Leadership Team
June 30, 2021
From
Tenaya Therapeutics
Via
Business Wire
Tenaya Therapeutics Receives Orphan Drug Designation and Presents Pre-Clinical Data for its Most Advanced Gene Therapy Product Candidate for Genetic Hypertrophic Cardiomyopathy
May 20, 2021
From
Tenaya Therapeutics
Via
Business Wire